Skip to main content

Recovery Housing Investment Program (RHIP)

Payouts of the nationwide settlement with the three largest pharmaceutical distributors, McKesson, Cardinal Health, and AmerisourceBergen (“Distributors”), and manufacturer Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson (collectively, “J&J”) have begun in State and local governments within Michigan. The total payout to Michigan will be $800 million dollars received over 18 years. A restricted fund, the Michigan Opioid Healing and Recovery Fund, was established within the Treasury through the passing of Public Act 83 of 2022.

The Michigan Department of Health and Human Services (MDHHS) has been authorized to spend $62.4 million of the initial settlement payment. MDHHS will use the funding to continue to support evidence-based programming to service individuals with substance use disorders. Of these funds, $2.5 million will be distributed through Michigan State Housing Development Authority (MSHDA) under the Recovery Housing Investment Program (RHIP) to expand access to recovery housing for people with Opioid Use Disorder (OUD) and any co-occurring substance use disorder (SUD) or mental health condition(s). The awarded funds will be structured as forgivable loans (grants) to purchase or lease single family homes or small multifamily properties for use as recovery housing. Applicants selected for funding must be certified by the Michigan Association of Recovery Residences (MARR) and/or the Commission on Accreditation of Rehabilitation Facilities (CARF) as detailed within this Request for Proposals (RFP). It is estimated that this investment will enable an additional 40-60 recovery homes that will serve 250-350 people in recovery, with priority given to populations of highest need, based on MDHHS's Michigan Overdose Data Action Dashboard.

Funding Opportunities:

New! FY2024-2025